IP Library › Patent Application 63351117
Patent Application Provisional
App. No. 63/351,117 · Confirmation No. 5395

Combination Therapy Comprising SIRP Alpha Fusion Protein and Anti-CD19 Antibody for Treatment of Cancer

Applicant: Pfizer Inc.
Provisional Application Expired
⬇ PDF
 Code Description Pages PDF
2023-05-25 N570 Communication - Re: Power of Attorney (PTOL-308) 1 View
2023-05-15 PA.. Power of Attorney 2 View
2023-05-15 N417 Electronic Filing System Acknowledgment Receipt 2 View
2023-01-26 R48.REQ.G Acceptance of Request under Rule 48 to correct inventorship or name 1 View
2023-01-26 APP.FILE.REC Filing Receipt 3 View
2023-01-24 R48.REQ Request under Rule 48 correcting inventorship 3 View
2023-01-24 ADS Application Data Sheet 10 View
2023-01-24 N417 Electronic Filing System Acknowledgment Receipt 2 View
2023-01-24 N417.PYMT Electronic Fee Payment 2 View
2022-06-16 APP.FILE.REC Filing Receipt 3 View
2022-06-10 CRFE Sequence Listing in Computer Readable Format, No errors found 13 View
2022-06-10 CRFE Sequence Listing in Computer Readable Format, No errors found — View
2022-06-10 ADS Application Data Sheet 8 View
2022-06-10 SPEC Specification 30 View
2022-06-10 CLM Claims 7 View
2022-06-10 DRW Drawings-only black and white line drawings 1 View
2022-06-10 WFEE Fee Worksheet (SB06) 2 View
2022-06-10 N417 Electronic Filing System Acknowledgment Receipt 3 View
2022-06-10 SEQ.TXT Sequence Listing (Text File) 1 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
63/351,117
Filed
2022-06-10